RWHAP Part B Supplemental Expenditures Report Manual
Resource updated 06/27/2024
Resource updated 06/27/2024
Resource updated 11/08/2023
Resource updated 01/29/2024
Doub elijibilite Medicare-Medicaid la kapab yon sijè konplèks ki gen anpil niyans. Zouti sa a se pou ede moun ki enfekte ak VIH konprann fondman elijibilite ak pwoteksyon asirans lan, avantaj inik ki genyen lè moun doubman elijib pou toulede pwogram yo, ansanm ak kijan Pwogram Ryan White VIH/SIDA (RWHAP) a kapab sipòte kliyan ki doubman elijib yo.
Zouti sa a abòde:
Resource updated 01/10/2024
La doble elegibilidad para Medicare-Medicaid puede ser un asunto complejo con muchas particularidades. Este recurso fue preparado con la intención de ayudar a las personas con VIH a entender los aspectos básicos relativos a la elegibilidad y la cobertura, los beneficios particulares de ser doblemente elegible para ambos programas, y cómo el Programa Ryan White contra el VIH/SIDA (RWHAP, por sus siglas en inglés) puede apoyar a los usuarios con doble elegibilidad.
Este recurso cubre los siguientes aspectos:
Resource updated 01/10/2024
Resource updated 10/30/2023
Resource updated 11/02/2023
Medicare-Medicaid dual eligibility can be a complex topic with many nuances.
This tool is intended to help people with HIV understand the basics of eligibility and coverage, the unique benefits of being dually eligible for both programs, as well as how the Ryan White HIV/AIDS Program (RWHAP) can support dually eligible clients.
This tool covers:
Resource updated 01/12/2024
Orientation guide for Part B Program Directors, staff and others.
Resource updated 11/02/2023
Suggested format for ADAP work plans.
Resource updated 09/19/2023
Planning and implementation steps when using a Pharmacy Benefit Manager (PBM) to administer an AIDS Drug Assistance Program (ADAP).
Resource updated 09/19/2023
Resource updated 05/29/2024
Resource updated 05/29/2024
NASTAD’s National AIDS Drug Assistance Program (ADAP) Formulary Database provides an online, searchable, publicly available resource detailing state-by-state ADAP coverage of medications, including HIV antiretroviral (ARV) treatments, “A1” Opportunistic Infections (A1 OI) medications, treatments for hepatitis B and C, mental health and substance use treatment medications, and various vaccines and laboratory tests.
Resource updated 03/07/2024
Resource updated 05/29/2024
Guide to help ADAPs prepare for and manage emergencies in order to ensure continued access to HIV medications.
Resource updated 09/19/2023
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
Resource updated 09/20/2023
Tools developed by a Part A program to monitor programs and services.
Resource updated 09/19/2023
CPAPA is no longer being updated by NASTAD and has been replaced by Pharmaceutical Company Patient Assistance Programs and Cost-Sharing Assistance Programs.
Resource updated 10/31/2023
Resource updated 02/22/2024